How your business can get smarter

 

Global Pricing | Reimbursement

Map Global Reimbursement & Coverage Landscape, Perform Primary Research with Payers to Inform Trial Design & Go No Go Decisions.

Economic Models | Evidence Synthesis  

Planning for evidence generation and synthesis to support economic models must therefore start early in product development.

Comparative Effectiveness | Real World Evidence

Quantitative research into treatment, disease burden, and resource use to inform multiple elements of the market access strategy.

Global Payer | KOL Advisory Boards

Identify & Engage all relevant KOLs and Payers around the globe based on tailored segmentation criteria with a Digital Interface.

White-Space-Mapping

Disrupt or be disrupted, Explore Game Changing Innovation Based on Predictive Analytics and Design Thinking. Scout Innovation more effectively, expand your global reach.

Patient-Reported-Outcomes

Explore strategies to optimize patient-reported outcomes to support the value proposition to regulators, reimbursement agencies, and patients.

Market Access Identification Mapping

Transform Market Access & Reach Payer Decision Makers.

Payer Readiness Assessment (PRA)

PRA™ is a strategic planning tool designed to evaluate the planned and required evidence for your product on a country-by-country basis.

Big Data & Real World Analytics

Maximize commercial Value with Real world Evidence

We Work with Amazing Brands

Our clients include over 20% of the 50 largest life science companies in the world by market capitalization, we’re also behind the success of many smaller category leaders across a broad range of therapeutic areas.

Explaining Real World Evidence

Outlined below is a video describing real world evidence.